Sentinel lymph node biopsy in male patients with early breast cancer

Oreste Gentilini, Eduardo Chagas, Stefano Zurrida, Mattia Intra, Concetta De Cicco, Giovanna Gatti, Luzemira Silva, Giuseppe Renne, Enrico Cassano, Umberto Veronesi

Research output: Contribution to journalArticlepeer-review


Mastectomy with axillary dissection is still the most commonly recommended procedure for male breast cancer. The aim of this study was to retrospectively evaluate our experience in 32 male patients with early breast cancer who underwent sentinel lymph node biopsy (SLNB) and axillary dissection only in cases of metastases in the sentinel lymph node (SLN). The median age was 58 years (range, 33-80). Lymphoscintigraphy was successful in all patients, with a mean number of visualized SLNs per patient of 1.3 (range, 1-2). At surgery, the identification rate of the SLN was 100%, with a mean number of removed SLNs per patient of 1.5 (range, 1-3). Twenty-six patients had negative SLNs, six patients had positive SLNs. Two patients with metastatic SLNs had additional positive nodes. After a median follow-up of 30 months (range, 1-63) no axillary reappearance of the disease occurred. As with women, we recommend SLNB in male patients with breast cancer and clinically negative axilla.

Original languageEnglish
Pages (from-to)512-515
Number of pages4
JournalThe oncologist
Issue number5
Publication statusPublished - 2007


  • Male breast cancer
  • Sentinel lymph node
  • Surgical treatment

ASJC Scopus subject areas

  • Cancer Research
  • Hematology


Dive into the research topics of 'Sentinel lymph node biopsy in male patients with early breast cancer'. Together they form a unique fingerprint.

Cite this